Inactive Instrument

News MTS Medication Technologies, Inc.

Equities

US5537731029

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MTS Medication Technologies : MACOM and Amphenol Support Ross Video for Industry's First 12G SDI openGear Platform	16-04-19	PU
MTS Medication Technologies : MACOM Announces Industry's First CWDM4 L-PIC™ for 100G Datacenter Applications	16-03-08	PU
MTS Medication Technologies : MACOM Showcases Industry's Broadest Portfolio of RF to Light Solutions for Wireless Network Infrastructure	16-02-18	PU
MTS Medication Technologies : MACOM SPARTM Tiles Selected by Massachusetts Institute of Technology's Lincoln Laboratory as Testbed for the DARPA ACT Radar Development Program	15-11-11	PU
MTS Medication Technologies : MACOM's 12G Chipset Selected for Marshall Electronics' New 12G-SDI Broadcast Converters	15-09-14	PU
MTS Medication Technologies : MACOM Completes Divestiture of Automotive Business	15-08-17	PU
MTS Medication Technologies : MACOM to Showcase Optical Portfolio Solutions at CIOE 2015 in Shenzhen, China from August 31 - September 3, 2015	15-08-10	PU
MTS Medication Technologies : MACOM Announces Fourth Generation GaN Technology	15-05-13	PU
MACOM Announces Upsize and Pricing of Public Offering of Common Stock	15-02-05	GL
MACOM Announces Proposed Public Offering of Common Stock	15-02-02	GL
MACOM Reports Revenue of $114.9 Million With EPS $0.38 and Gross Margin of 53.7 Percent (Non-GAAP)	15-02-02	GL
MACOM to Present at the Stifel Technology, Internet and Media Conference on February 10	15-01-21	GL
MACOM to Announce First Quarter Fiscal 2015 Financial Results on February 2, 2015	15-01-12	GL
MACOM to Present at the Needham Growth Conference on January 13	14-12-22	GL
MACOM Successfully Completes Acquisition of BinOptics Corporation	14-12-16	GL
MACOM to Participate at the Barclays Global Technology Conference on December 9	14-11-20	GL
MACOM Reports Strong Growth; Revenue of $114.3 Million With EPS of $0.35 and Gross Margin of 54.1 Percent (non-GAAP)	14-11-18	GL
MACOM Announces Definitive Agreement to Acquire BinOptics Corporation	14-11-18	GL
MACOM to Announce Fourth Quarter Fiscal 2014 Financial Results on November 18, 2014	14-10-21	GL
MTS Medication Technologies : MACOM Announces Industry's Leading Up-Converter for 28 - 34 GHz Point-to-Point Radio Applications	14-09-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MTS Medication Technologies, Inc.

Equities

US5537731029

Summary

Filters